CMT BOS Pharmacology Flash Cards

Play Memory | Create Card File | Append to Card File
Title: CMT BOS Pharmacology
Description: Chapter 13 terms from Book of Style 3rd Edition
Number of Cards: 101
Save Count: 1
Author: mssonger7
Created: 2012-02-13
Tags: medical rmt/cmt transcription
Private No

Save Count represents the number of people who have saved this card set to their flashcard list. Consider this an endorsement!

    • Question
    • Answer
    • Side 3
    • Chemical elements used with lasers
      and may be combined and abbreviated in laser references
    • aluminum, argon, chromium, erbium, garnet, helium, holmium, neodymium, rhodamine, ruby, thulium, yttrium
    • amino acids of proteins
    • phenylalanine Phe, F
      proline Pro, P
      tryptophan Trp, W
    • bases and nucleosides
    • cytosine Cyt
      purine Pur
      uracil Ura
    • common ribonucleosides
    • adenosine Ado, A
      cytidine Cyd, C
      uridine Urd, U
    • sugars and carbohydrates
    • fructose Fru
      glucose Rib
    • Drug development
    • Phase 1: Studies conducted in healthy volunteers to assess safety, effects, metabolism, kinetics, and drug interactions
    • Drug development
    • Phase 2: Studies conducted to establish therapeutic efficacy and determine dose range.
    • Drug development
    • Phase 3: Trials typically randomized, controlled studies that assess safety/efficacy in a large sample of patients (2000-3000) for whom the drug is anticipated to be effective.
    • Brand name drug
    • manufacturer's name, same as a trademark name.
    • Trade name
    • broader term than trademark, identifying the manufacturer, not the product.
    • Code name
    • temporary designation for an as-yet-unnamed drug, assigned by the manufacturer. May include a code number or code designation.
    • Chemical name
    • Describes the chemical structure of a drug
    • Brand name
    • Proprietary name, manufacturer's name for a drug, same as trademark name
    • Generic name
    • nonproprietary name, official drug name. Created by US Adopted Names Council (USAN). Ensures consistent usage and nonduplication.
    • DEA
    • Drug Enforcement Administration
    • Drugs of Abuse Scheduling
    • Schedule I: Drugs deemed to have a high risk for abuse/dependence for which there is no current recognized clinical application/use.
      Ex. PCP, heroin, LSD, marijuana
    • Drugs of Abuse Scheduling
    • Schedule II. Drugs deemed to have a high risk for abuse/dependence that also have current clinical applications.
      Ex. opium, morphine, cocaine
    • Drugs of Abuse Scheduling
    • Schedule III: Drugs deemed to have some risk for abuse/dependence that also have a high degree of clinical application/use. Ex amphetamine, Valium, codeine
    • Drugs of Abuse Scheduling
    • Schedule IV: Drugs deemed to have a limited risk for abuse/dependence that also have a high degree of clinical application/use. Ex. chloral hydrate, phenobarbital
    • Drugs of Abuse Scheduling
    • Schedule V: Drugs deemed to have a low risk for abuse/dependence that are used for clinical research or represent the above drugs used in limited amounts for specific applications.
    • Dose
    • amount to be administered at one time or total amount administered
    • Dosage
    • regimen expressed as a quantity per unit of time
    • a.c.
    • ante cibum (before food)
    • b.i.d.
    • bis in die (twice a day)
    • gtt.
    • guttae (drops)
    • n.p.o.
    • nil per os (nothing by mouth)
    • n.r.
    • non repetatur (do not repeat)
    • p.c.
    • post cibum (after food)
    • p.o.
    • per os (by mouth)
    • p.r.n.
    • pro re nata (as needed)
    • q.4 h.
    • quaque 4 hora (every 4 hours)
    • q.h.
    • quaque hora (every hour)
    • q.i.d.
    • quater in die (4 times a day)
    • t.i.d.
    • ter in die (3 times a day)
    • u.d.
    • ut dictum (as directed)
    • USP
    • United States Pharmacopeia
    • hypothalmic hormones that stimulate the release of pituitary hormones (suffix)
    • relin
    • hypothalmic hormones that inhibit the release of pituitary hormones (suffix)
    • relix
    • TRH
    • thyrotropin-releasing hormone
    • LHRH
    • luteinizing hormone-release hormone
    • GnRH
    • gonadotropin-releasing hormone
    • GHRF
    • growth hormone-releasing factor (somatorelin)
    • GHRIF
    • growth hormone release-inhibiting factor (detirelix acetate)
    • growth hormone ( suffix som-)
    • somatrem,somidobove, sometribove, somagrebove, somalapor, somenopor, sometripor, somfasepor
    • T4
    • levorotatory thyroxine
    • T3
    • tridothyronine
    • dextorotatory triiodothyronine
    • dextrothyroxine sodium
    • liothyronine and levothyroxine sodium
    • liotrix sodium
    • human insulin
    • derived from human DNA
      human insulin injection (Humulin)
    • porcine insulin
    • synthetic type of insulin, generally modified
    • human insulin injection
      nonproprietary name expressed in % in combination form
    • Humulin
      proprietary name expressed with virgule (?) in combination form
    • insulin lispro injection
      nonproprietary name expressed in % in combination form
    • Humalog
      proprietary name expressed with virgule (?) in combination form
    • insulin aspart injection
      nonproprietary name expressed in % in combination form
    • NovoLog
      proprietary name expressed with virgule (?) in combination form
    • insulin glargine injection
      nonproprietary name expressed in % in combination form
    • Lantus
      proprietary name expressed with virgule (?) in combination form
    • prompt insulin zinc suspension
      nonproprietary name expressed in % in combination form
    • Emilente
      proprietary name expressed with virgule (?) in combination form
    • insulin zinc suspension
      nonproprietary name expressed in % in combination form
    • Lente
      proprietary name expressed with virgule (?) in combination form
    • extended human insulin zinc suspension
      nonproprietary name expressed in % in combination form
    • Ultralente
      proprietary name expressed with virgule (?) in combination form
    • insulin isophane suspension
      nonproprietary name expressed in % in combination form
    • NPH
      proprietary name expressed with virgule (?) in combination form
    • Interferons
    • glycoproteins that exert antineoplastic, antiviral, and immuno-modulating effects
    • general classes of compounds or single compounds of interferons
    • interferon alfa or IFN-greek symbol
      interferon beta or IFN-greek symbol
      interferon gamma or IFN-greek symbol
    • individual, pure, identifiable compound interferons
    • expressed as:
      ex. interferon alfa-2a
    • mixtures of interferons from natural sources
    • expressed as:
      interferon alfa-n1
    • Interlukens
    • class of proteins secreted mostly by macrophages and T lymphocytes. They induce growth and differentiation of lymphocytes and hematopoietec stem cells
    • interleukin 1 derivatives
    • nakin
    • interleukin 1a derivatives
    • onkain
    • interleukin 1b derivatives
    • benakin
    • interleukin 2 derivatives
    • leukin
    • interleukin 4 derivatives
    • trakin
    • interleukin 5 derivatives
    • penkin
    • interleukin 6 derivatives
    • exakin
    • interleukin 7 derivatives
    • eptakin
    • interleukin 8 derivatives
    • octakin
    • interleukin 9 derivatives
    • nonakin
    • interleukin 10 derivatives
    • decakin
    • interleukin 11 derivatives
    • elvekin